Element Biosciences Stock
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
Sign up today and learn more about Element Biosciences Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Element Biosciences Stock
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. We are developing a modular and high-performing DNA sequencing platform that will deliver high quality data, workflow flexibility, and make next-generation sequencing technology more accessible. Our proprietary approach to improve the signal-to-noise ratio allows us to provide groundbreaking innovations in surface chemistry, instrumentation and biochemistry to drastically decrease the run cost and capital cost while delivering high sequencing data quality.
Funding History
June 2019 | $15.0M |
---|---|
January 2020 | $80.0M |
June 2020 | $30.0M |
June 2021 | $276M |
Management
CEO
Molly He
CTO & Co-Founder
Michael Previte
Chairman
John Stuelpnagel
Vice President Finance
Logan Zinser
Board Member
Jim Tananbaum
Co-Founder
Matt Kellinger
Vice President, Human Capital Management
Steve Potter
Board Member
Bryan Roberts
Senior Vice President Of Engineering
Francisco Garcia
Press
patents - Apr, 14 2024
Methods for preparing nucleic acid nanostructures using compaction …patents - Apr, 14 2024
Flow cell device and use thereofpatents - Apr, 14 2024
Spatially resolved surface capture of nucleic acidspatents - Apr, 14 2024
Pcr-free library preparation using double-stranded splint adaptors and methods …patents - Apr, 14 2024
Engineered polymerases with improved thermal stability